Gabapentin Tablet
Product Images NDC 82804-015

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of Gabapentin, showing a cyclohexane ring bonded to an amino group (CH2NH2) and an acetic acid group (CH2CO2H).*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day groups. The x-axis shows time in weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10. Gabapentin shows a steady decrease in pain scores, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph depicting mean pain scores over 7 weeks, comparing placebo with Gabapentin at daily doses of 1800 mg and 2400 mg. The x-axis shows weeks from baseline to week 7, and the y-axis shows mean pain score from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Gabapentin 04)

Bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) to gabapentin (GBP) at doses 1800 mg, 2400 mg, and 3600 mg in two separate studies. Y-axis shows percentage response from 0% to 100%. Gabapentin groups show higher response percentages than placebo groups, with noted significance levels (p < 0.01, p < 0.001) indicated by asterisks.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot chart comparing differences (%) at various daily doses (600 mg to 1800 mg) of gabapentin across three studies labeled a, b, and c. The y-axis represents difference (%) and the x-axis represents daily dose in milligrams. Study a is marked with black squares, Study b with gray squares, and Study c with white squares.*

FDA Label Image

82804-015-90 (Gabapentin 06)

Gabapentin 600 mg oral tablets label by Proficient Rx LP. The label shows a 90-count bottle with each film-coated tablet containing 600 mg gabapentin. Tablets are described as white to off white, biconvex with specific debossed markings. The label includes storage instructions and manufacturer ScieGen Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.